AstraZeneca beats estimates on strong emerging market sales as COVID wanes ...Middle East

Devdiscourse - Opinion
AstraZeneca beats estimates on strong emerging market sales as COVID wanes
AstraZeneca on Thursday beat expectations for first-quarter profit and revenue, as buoyant sales of cancer treatment Imfinzi and strong demand for its roster of drugs in emerging markets helped to offset dwindling COVID product sales. The company's sales and outlook highlight the rapid decline of its COVID vaccine, its best-selling product in 2021 at the height of the pandemic, which has struggled to compete with rival shots developed by Pfizer and Moderna.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca beats estimates on strong emerging market sales as COVID wanes )

Apple Storegoogle play

Also on site :